Funding News

HealthQuad Has Closed Rs 550 Crore for Fund III — Backed by Quadria, Targeting Rs 1,700 Crore, First Bet Already Made in an AI Remote Patient Monitoring Platform

By Darshan S, Editor · 01 July,2026 · 2 min read

Summary

• HealthQuad Fund III: Rs 550 Crore First Close, Targeting Rs 1,700 Crore for India's Next Wave of HealthTech Innovation
• Quadria Group-backed HealthQuad has closed Rs 550 crore for Fund III, targeting Rs 1,700 crore for early-growth healthtech, medtech, and biopharma companies. First investment: Lifesigns AI remote patient monitoring.

"Healthcare is undergoing one of the most significant transformations in recent times. The next decade will be defined by companies that leverage emerging technologies and AI, and innovative models to make healthcare more accessible, affordable, and outcome-driven. HealthQuad was created with a simple belief that healthcare requires specialist investors who understand the sector deeply and can support founders through long, arduous growth journeys."

HealthQuad, the healthcare-focused venture capital firm backed by Quadria Group, has announced the first close of its third investment vehicle — HealthQuad Fund III — securing Rs 550 crore in commitments from a mix of existing and new limited partners. The Rs 550 crore first close represents more than one-third of the fund's target corpus of Rs 1,700 crore, with a greenshoe option that could extend the total to Rs 2,500 crore. HealthQuad expects to close the fund fully by mid-2027.

The investor base reflects a broadening of the HealthQuad limited partner community beyond the firm's existing relationships: commitments have come from both returning investors in HealthQuad's earlier funds and new domestic and international fund-of-funds, institutions, and family offices. Fund III is managed by HealthQuad Advisors Private Limited, a wholly owned subsidiary of Quadria Group, with Amit Varma, Abrar Mir, and Sunil Thakur as the investment committee's key persons, expanded by the addition of Rahul Agarwal and Namit Chugh following the mutual separation of Quadria Group and KOIS in 2025.

The First Investment: Lifesigns

Alongside the first close announcement, HealthQuad confirmed its initial deployment from Fund III: an investment in Lifesigns, an AI-powered remote patient monitoring platform. Lifesigns sits precisely at the intersection of the investment themes Fund III has articulated — AI-enabled healthcare delivery that addresses the persistent gaps in India's remote monitoring infrastructure, particularly for chronic disease management and post-discharge cardiac monitoring.

The Lifesigns investment connects directly to a category BHC Media has been tracking throughout 2026: AI-enabled hospital-to-home care extension. Narayana Health's virtual cardiac ward monitoring 10,000 patients at home (covered June 1 edition) and Orange Health Labs' Orange One preventive health subscription (covered June 25 edition) both reflect the structural shift toward monitored care delivery extending beyond hospital walls. Lifesigns positions itself as an AI platform enabling this extension at scale.

The Fund's Investment Universe

HealthQuad Fund III will continue the strategy of Funds I and II — targeting early-growth companies with proven commercial traction across HealthTech, MedTech, Bio/Pharma Technology, and innovative healthcare delivery platforms. The firm describes these sectors as expanding at an estimated 16-40% annually, collectively projected to contribute more than 40% of India's $600 billion healthcare market by 2030.

Critically, Sunil Thakur articulated a deliberate division of territory between Quadria Capital (the parent PE fund focusing on conventional healthcare businesses such as hospitals, eye care, dialysis, and pharmaceutical manufacturing) and HealthQuad (focusing on technology-led models including AI diagnostics, remote patient monitoring, digital tools for hospitals and clinicians, medtech, bio-pharma technology, and newer healthcare delivery platforms). The two vehicles can invest in the same company at different stages, but the investment focus is intentionally distinct.

The Fund I and II Portfolio Track Record

HealthQuad's investment thesis is built on a decade of backing early-growth healthcare companies through its first two funds — and the portfolio that has emerged includes several of India's most recognised digital health platform companies. Qure.ai (AI medical imaging, with Gates Foundation grants and FDA clearances), Redcliffe Labs (diagnostics platform), Wysa (AI mental health), CureSkin (dermatology AI), Medikabazaar (hospital procurement), Strand Life Sciences (genomics), THB (healthcare analytics), ekincare (employee health), and GoApptiv (pharma commercial intelligence) — these companies collectively define what HealthQuad's early-growth investment model has produced.

Rahul Agarwal, Partner and IC Member, expressed the thesis directly: the next decade will be defined by companies that leverage emerging technologies and AI, and innovative models to make healthcare more accessible, affordable, and outcome-driven.

"BHC Perspective"

At Bengaluru Health Community, HealthQuad Fund III is the single most significant dedicated healthcare venture capital vehicle to announce a first close in India in 2026. For BHC founders building in HealthTech, MedTech, or biopharma technology — Fund III at Rs 1,700 crore target represents a well-credentialed, deeply specialised investor actively seeking early-growth healthcare companies to back. For BHC's Mentorship Platform — HealthQuad's senior team represents exactly the calibre of investor mentors that BHC's healthcare founder community needs access to.

Frequently Asked Questions

Q: What is HealthQuad Fund III?
A: A Rs 1,700 crore target (greenshoe Rs 2,500 crore) early-growth healthcare VC fund backed by Quadria Group, with Rs 550 crore secured at first close. Focuses on HealthTech, MedTech, Bio/Pharma Technology, and innovative healthcare delivery models. First investment: Lifesigns, an AI remote patient monitoring platform.

Q: What is HealthQuad's portfolio track record?
A: Funds I and II backed 18+ companies including Qure.ai, Wysa, Redcliffe Labs, CureSkin, Medikabazaar, Strand Life Sciences, THB, ekincare, and GoApptiv — a portfolio that now defines India's first generation of digital health infrastructure companies.

Q: How does HealthQuad differ from Quadria Capital?
A: Quadria Capital focuses on conventional healthcare businesses (hospitals, eye care, dialysis, pharmaceutical manufacturing). HealthQuad backs technology-led healthcare models (AI diagnostics, remote patient monitoring, digital hospital tools, medtech, biopharma tech, novel delivery platforms). The two can co-invest at different stages.